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ABSTRACT
The successful Programa Nacional de Imunizações do Brasil (Brazilian National Immunization 
Program) has been experiencing a major challenge with regard to vaccination coverage for 
children, which has been dropping. Several aspects are related, but certainly vaccine hesitancy 
has been strengthening itself as one of the main concerns of Brazilian public administrators 
and researchers. Vaccine hesitancy is the delay in acceptance or refusal despite having the 
recommended vaccines available in health services, being a phenomenon that varies over 
time, over location and over types of vaccines. Hesitant individuals are between the two poles 
of total acceptance and refusal of vaccination. Vaccine hesitancy is nothing new in European 
and North-American countries, and even in Brazil, it has been studied even if under another 
name. The drop of vaccination coverage observed from 2016 on reiterates the relevance of the 
theme, which must be better understood through scientific research.
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INTRODUCTION
Eradication of smallpox and control of vaccine-preventable diseases were possible throughout the 
world1–3 because of vaccination, through successful immunization programs. Global initiatives 
have contributed substantially to the development of these programs in middle- and low-income 
countries. The Expanded Programme on Immunization (EPI) of the World Health Organization 
(WHO), established in 1974, promoted access to vaccination, indicated by the increase in coverage 
of the diphtheria-tetanus-pertussis (DTP) vaccine4. The challenge became the equity of access 
to new vaccines. Thus, the Global Alliance for Vaccines and Immunization was created in 2000 
with the objective of providing this access to every social stratum in low-income countries1.
The Programa Nacional de Imunizações do Brasil (Brazilian National Immunization Program 
– PNI) is recognized for promoting the free vaccination of more than 15 antigens. It has 
been getting increasingly complex, both by expanding the number of vaccines provided as 
by the diversification of immunization schedule5. Paradoxically, such advancement brings 
challenges inherent to its evolution, because the disease control from high vaccination 
coverage influences the perception of risks and benefits for vaccination6.
Since the 1990s, the vaccination coverage for children were above 95%5, which indicates 
good adherence of the population to vaccination. However, since 2016 such coverage has 
been declining about 10 to 20 percentage pointsa. This was unexpected and came with an 
increase in infant and maternal mortalityb. Measles epidemics in Roraima and in Amazonas 
are immediate consequences of the decrease in vaccination coveragec.
Several factors are related to this drop, whether the weakening of the Brazilian Unified 
Health System (SUS), or of the technical aspects, such as the development of the new 
immunization information system, whether the social and cultural aspects that affect the 
acceptance of vaccination5,7–10.
Anti-vaccine movements are growing and being strengthened by the increase in incorrect 
health information shared especially in the internet11. Vaccine hesitancy is an old concern 
of researchers from European and North American countries12–14. In Brazil, few studies were 
developed about this phenomena10, but vaccine hesitancy has become increasingly evident.
The drop in vaccination coverage for children and its visible consequences justify the effort 
to better understand vaccine hesitancy in Brazil. Thus, the objective of this comment is 
to present the definition and factors related to vaccine hesitancy, as well as discuss its 
importance in the Brazilian context.
Vaccine Hesitancy: Definition and Related Factors
Hesitancy comes from the Latin word hæsitātĭō and is defined by the state of hesitating, i.e. of 
being indecisive at the moment of making decisions15. In 2012, the WHO formed the Strategic 
Advisory Group of Experts – Working Group (SAGE-WG) to define vaccine hesitancy, to 
understand its magnitude as well as the factors that influence it, and to systematically 
gather evidence of interventions in public health16.
Vaccine hesitancy is defined as the delay in acceptance or refusal of recommended vaccines, 
despite their availability in health services16. This behavioral phenomenon is quite complex 
compared to its determinants (which involve cultural, social, and economic aspects), and 
varies over time, over location and over types of vaccines12,13,16.
It should be understood as a continuum between those who undoubtedly accept and 
those who undoubtedly refuse all vaccines, i.e. hesitant individuals are between these two 
extremes. They form heterogeneous groups, in which a few people only accept some vaccines 
and others delay it on purpose, not accepting the recommended vaccination schedule. In 
smaller proportion, there are those who refuse only some vaccines and those who still have 
doubts about the decision of having a vaccination or not13,16,17.
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This behavior is influenced by several interrelated factors such as confidence, complacency 
and convenience, known as the “3Cs” model, proposed by WHO in 2011. Confidence is about 
the effectiveness and safety of vaccines, the health system that delivers them, and the public 
administrators’ motivations for recommending them. Complacency results from the low risk 
perception of contracting diseases so that vaccination would be considered unnecessary. 
Finally, convenience considers physical availability, willingness to pay, geographical 
accessibility, ability to understand and access to health information16.
In 2012, the SAGE-WG defined a matrix of determinants to vaccine hesitancy considering 
individual and contextual characteristics and specific vaccination issues. In short, the 
domain of contextual influences includes historical, geographical, political, socioeconomic, 
cultural, religious, and gender aspects, as well as communication and media, influence 
of leaders and perception over the pharmaceutical industry. Individual influences are 
prior experiences with vaccination, beliefs and attitudes toward health, confidence to 
the health system, link with health professionals, vaccine risk perception, and vision of 
immunization as a social norm against that in which vaccination is not required or is 
harmful. Finally, the specific aspects of vaccine include risks and benefits, vaccination 
schedule, method of administration, introduction of a new vaccine or formulation, costs 
and supply of vaccines13,16.
We emphasize that vaccine hesitancy and its determinants vary over time and are specific 
to each context. Systematic reviews reiterate this heterogeneity, indicating the need of 
strengthening this knowledge in different contexts and qualifying immunization programs to 
approach it12,13,18. A study with public administrators of 13 countries showed that most of them 
interpreted hesitancy as vaccine refusal and some considered it a small problem12. Factors also 
differed among countries12; for example, the caregiver’s high educational level and favorable 
socioeconomic status do not influence vaccine hesitancy always in the same direction16.
A study with 67 countries, including Brazil, found that the general feeling in relation to 
vaccination is positive, but with a great variability. Safety outstood as the aspect that 
brings negative feelings, particularly in Europe. In addition, countries with high educational 
levels and good access to health services had the lowest rates of positive feelings about 
vaccination18. Percentages of Brazilians who responded to disagree with the importance, 
safety, and effectiveness of vaccines were 0.7%, 6.1%, and 4.5%, respectively, very below 
other localities18.
Despite vaccine hesitancy being a recognized problem, its measurement is still a challenge. 
The SAGE-WG also developed, from other previously validated questionnaires19,20, three 
instruments about vaccine hesitancy with different types of questions: basic closed-ended, 
Likert scale and open-ended21. The Box presents the instrument in Likert-scale translated 
into Portuguese, but still not validated.
And how to deal with the vaccine hesitancy? Systematic reviews concluded that there is no 
strong evidence to recommend specific interventions. In general, most interventions had 
more than one component and those directed to the increase in knowledge (communication 
strategies, media, social mobilization, information tools for health professionals) outstood. 
Also, we can cite interventions based on non-financial incentives and on scheduling 
strategies, as well as call-up for vaccination directed to the target population22.
The Anti-Vaccine Movement and its Consequences
The anti-vaccine movement is as old as the vaccination itself. In the United Kingdom, there 
were caricatures of smallpox vaccine since the 1800s. The compulsory vaccination caused 
resistance of individuals that considered it an invasion of freedom over their own body. In 
the United States, court fights against compulsory vaccination were not rare in the 1920s. 
Nevertheless, in high-income countries, the 1950s and 1960s were considered the “golden age 
of vaccine acceptance” with the introduction of universal vaccination against poliomyelitis 
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and measles-mumps-rubella (MMR), resulting in the significant decline of these diseases. 
On the other hand, middle- and low-income countries started this phase in the 1970s, with 
the support of EPI11.
From 1980 on, the controversy of whole-cell pertussis vaccine started, culminating in the 
development of acellular vaccine. In the United States, a passive surveillance system was 
created for adverse events following immunization, for, besides better monitoring these 
events, providing more transparency to the population. In the 1990s, articles about the 
possible association between MMR vaccine and Crohn disease were published and later, 
about the connection of this vaccine with autism. Even after publication of other studies 
refuting this relationship, this feeling still lingers in the population and such information 
is disseminated nowadays in a more agile manner through the internet11.
The consequences are the frequent epidemics of vaccine-preventable diseases, as measles 
and whooping cough, that currently occur throughout the world23, and the threat of 
reintroduction of poliomyelitis in regions where it had been already eliminated24. In Europe, 
in the first eight months of 2018, more than 41,000 cases of measles occurredd. In the United 
States, a substantial proportion of measles cases occurred in intentionally-unvaccinated 
individuals. Similarly, vaccine hesitancy also played an important role in the reemergence 
of whooping cough, despite being attributed to immunity loss23.
Importance of Vaccine Hesitancy in the Brazilian Context: Challenges and Perspectives
Anti-vaccine movements in Brazil are also old. The most well-known manifestation was the 
Revolta da Vacina (Vaccine Revolt) in 1904, with the law of compulsory smallpox vaccination. 
However, the critical framework of the disease that devastated the country caused the 
population to quickly seek the vaccine25.
Since the 1990s, vaccination coverage in Brazil is high, which reflects the good acceptance 
by part of the population. The improvement of PNI and the advancement of research, 
development, and production of immunobiological agents in the country contributed to 
this success. Certainly, national vaccination campaigns and days favored this adherence, 
since they expressed public mobilization. Also, communication and media of vaccination 
actions improved, with simpler language, exploring the ethnic diversity and calling-up 
national heroes25. As direct consequence of the PNI success, vaccine-preventable diseases 
were controlled2.
However, this scenario is changing rapidly. Between 2013 and 2015, 1,310 cases of measles 
were recorded in the states of Ceará and Pernambuco. In 2018, these epidemics reemerged 
in the states of Roraima and Amazonas with over 1,500 confirmed cases in the first eight 
months of such yeare. This statistic is a warning about the impact of the drop in vaccination 
coverage in general (Figure 1).
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Box. Instrument to study the hesitancy to child vaccination applied to parents or caregivers in Likert 
scale of 5 points.
How much do you agree with the following statements about vaccines? Please indicate your answer using the 
scale below:
1 = strongly disagree; 2 = disagree; 3 = neither agree nor disagree; 4 = agree; 5 = strongly agree
L1. Vaccines are important for my child’s health.
L2. Vaccines are effective.
L3. Having my child vaccinated is important for the health of others in my community.
L4. All childhood vaccines offered by the government are beneficial.
L5. New vaccines carry more risks than older vaccines. 
L6. I trust the information I receive about vaccines from the immunization program. 
L7. Getting vaccines is a good way to protect my child from disease.
L8. Generally I do what my health care provider recommends about vaccines for my child.
L9. I am concerned about serious adverse effects of vaccines.
L10. My child does not need vaccines for diseases that are not common anymore. 
Source: Adapted from Opel et al.19 and Larson et al.21
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Despite high national coverage, homogeneity is still a challenge5. Figure 2 shows the 
proportion of municipalities with coverage of DTP, measles and poliomyelitis vaccines ≥ 95%. 
One can note the high homogeneity in the first decade of the 2000s and a drop from 2014 on.
Figure 3 presents maps of measles vaccination coverage. Besides the obvious heterogeneity 
among municipalities, we notice a discreet improvement of coverage between 2005 and 2009 
and an important drop between 2013 and 2017. It is worth indicating some reservations about 
these data, as fluctuations resulting from the territorial size of the municipality and from 
its population. However, the figure illustrates the importance of continuous surveillance 
of vaccination coverage and of the quality of vaccination records.
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Data source of vaccination coverage: Ministério da Saúde (BR). Programa Nacional de Imunização. Sistema de 
Informação do Programa Nacional de Imunizações - SIPNI. Brasília (DF); 2018 [cited 2018 Sep 10]. Available 
from: http://sipni.datasus.gov.br/si-pni-web/faces/inicio.jsf 
* Data on DTP vaccination from 2002 to 2003 estimated by linear interpolation.
Figure 2. Brazilian municipalities that achieved vaccination coverage (VC) ≥ 95% for child vaccines 
diphtheria-tetanus-pertussis (DTP) (3rd dose), measles (1st dose) and poliomyelitis (3rd dose), from 
1994 to 2017.
Data source of vaccination coverage: Ministério da Saúde (BR). Programa Nacional de Imunização. Sistema de 
Informação do Programa Nacional de Imunizações - SIPNI. Brasília (DF); 2018 [cited 2018 Sep 10]. Available 
from: http://sipni.datasus.gov.br/si-pni-web/faces/inicio.jsf 
Data source of measles cases: Ministério de Saúde (BR), Secretaria de Vigilância em Saúde. Casos confirmado de 
sarampo. Brasil, Grandes Regiões e Unidades Federadas, 1990-2018., Brasília (DF); 2018 [cited 2018 Sep 10]. 
Available from: http://portalarquivos2.saude.gov.br/images/pdf/2018/abril/25/Casos-confirmados-sarampo.pdf 
a Measles cases confirmed in 1997 = 53,664.
b Data on vaccination coverage of 2018 estimated by linear interpolation. 
c Data on DTP vaccination from 2002 to 2003 estimated by linear interpolation.
d Measles cases confirmed in 2018, updated in August 27, 2018.
Figure 1. Historical series of vaccination coverage (VC) of diphtheria-tetanus-pertussis (DTP VC), measles 
(measles VC) and poliomyelitis (Polio VC) and measles cases confirmed from 1994 to 2018, Brazil.
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Few Brazilian studies investigated the voluntary refusal or delay to having vaccines available 
in SUS. Most studies did not name what we currently call vaccine hesitancy. Qualitative 
studies distinguished groups of parents that vaccinated their children (vaccinators), 
selective vaccinators and non-vaccinators. These studies show that the vaccination decision 
is influenced by sociocultural aspects, both unique from the Brazilian context and from 
the contemporary society7,8,26.
Vaccinator parents state vaccination as an act of duty and responsibility and do it without 
questioning, being influenced by family tradition and social norm7,8,26. Selective parents 
experienced different situations that put them in doubt about the decision of vaccinating 
their children or delaying it, characterizing the singling out of child vaccination, i.e. making 
it particular, before the extensive vaccination calendar of PNI7,8,26. On the other hand, among 
non-vaccinators, a more natural vision predominated, i.e. of less medical and hospital 
intervention in health processes, as well as the autonomy of parental decisions before the 
regulations on child care. Among the justifications for not vaccinating, there outstood: low 
perception of disease risk, since they are already under control or mild; fear of adverse events 
following immunization; questionings about its effectiveness and formulation and about the 
financial interest of the pharmaceutical industry; option for other forms of health protection7,8,26.
In a study in São Paulo, pity of the child receiving the injections was associated with the 
delay of measles vaccine for at least 20 days. The authors recommended having two or more 
communication channels and showed that the vaccine card is a tool that assists vaccination 
at the preconized age27. A review study on adverse events of vaccines provided by SUS 
showed that the risks associated with vaccines do not justify its disruption and that the risk 
associated with non-vaccination is growing. The authors also alerted the lack of information 
2017
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Data source of vaccination coverage: Ministério da Saúde (BR). Programa Nacional de Imunização. Sistema de 
Informação do Programa Nacional de Imunizações - SIPNI. Brasília (DF); 2018 [cited 2018 Sep 10]. Available 
from: http://sipni.datasus.gov.br/si-pni-web/faces/inicio.jsf 
Figure 3. Coverage of measles vaccine (1st dose) in 2005, 2009, 2013 and 2017, according to municipality, Brazil.
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and emphasized the role of health professionals9. The low proportion of individuals that 
know the human papillomavirus and its vaccine reinforced this demand for educational 
interventions28. There is evidence of vaccine hesitancy also among health professionals 
with low coverage of the full schedule of hepatitis B vaccine29, which indicates that the 
importance of vaccination must also be reinforced in the own training and continuing 
education of these professionals.
The media also has a crucial role in the search for vaccines. The 2007–2008 yellow fever 
outbreak was portrayed by the press coverage as an epidemic out of control, with no 
explanation of the sylvatic form of the disease and emphasizing the vaccine as the only 
salvation. The result was the indiscriminate pursuit of the population for the vaccine, 
even by people for whom vaccination was contraindicated30. From 2017 to 2018, similar 
problems were experienced, with an exaggerated demand for the vaccine; however, 
the introduction of fractional-dose vaccine and dispersal of incorrect news made the 
queues disappear.
FINAL CONSIDERATIONS
The drop in vaccination coverage instigated Brazilian public administrators and researchers 
to seek possible explanations. Vaccine hesitancy must be better understood in the Brazilian 
context. This phenomenon is nothing new in European or North-American countries, and 
even in Brazil, it has been studied, even if under another name7,8,10,13,14,26.
The poles of total acceptance or total refusal comprise relatively smaller groups than 
the hesitant ones, which also are distributed into heterogeneous groups. Generally, the 
interpretation of the vaccine risk is not based on rational evaluation of the evidence, but 
rather on the sense of uncertainties and ambiguities that remain even in the face of empirical 
evidence11. Thus, several studies emphasize the importance of communication and the link 
of population with vaccination actions.
Anti-vaccine movements, although ancient, have been gaining strength throughout the 
world, with a more visible start in high-income countries. However, certainly, the impact of 
this negative feeling regarding vaccines will be more important in middle- and low-income 
countries, as these movements are strengthened14. Therefore, it is imperative that Brazilian 
public administrators, researchers and the population mobilize themselves to protect our 
successful immunization program.
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